Icos Antibody Market: Immune Checkpoint Modulation Enhancing Cancer Immunotherapy Efficacy
Market Overview Inducible T-cell costimulator (ICOS) is a critical immune checkpoint receptor expressed on activated T cells, playing pivotal roles in T-cell proliferation, survival, and function. The ICOS Antibody Market is emerging within immuno-oncology as researchers explore agonistic ICOS antibodies to enhance anti-tumor immunity and antagonistic approaches for autoimmune modulation. The...
0 Comments 0 Shares 4 Views 0 Reviews
BuzzingAbout https://www.buzzingabout.com